Trials / Completed
CompletedNCT03985319
Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1)
A Randomized, Open-label, Cross-over Design Clinical Trial to Assess the Pharmacokinetic/Pharmacodynamic Properties and Safety of YYD601 20mg After Oral Administration in Healthy Adult Subjects (Phase1)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Yooyoung Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1)
Detailed description
To evaluate comparatively a characteristics and safety of the PK/PD of single/repeated oral administration YYD601 20mg and Nexium tab 20mg and the effects of food influence the PK/PD of YYD601 20mg in a healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YYD601 20mg | Esomeprazole IR 10mg + Esomeprazole SR 10mg (Expected efficacy and effects: GERD) |
| DRUG | Nexium tab 20mg | Esomeprazole magnesium trihydrate 22.3mg Effecacy and Effects: GERD and Antibiotics combined therapy to eradicate the Helicobacter pylori |
Timeline
- Start date
- 2019-07-08
- Primary completion
- 2020-02-07
- Completion
- 2020-03-20
- First posted
- 2019-06-13
- Last updated
- 2021-05-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03985319. Inclusion in this directory is not an endorsement.